Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study

Fig. 3

Cubic spline curve of adjusted hazard ratio for major cardiovascular events according to statin therapy duration. Adjusted HR* (solid line) and 95% CI (shaded area) for major cardiovascular events according to statin therapy duration were calculated with a reference of 3 months. *Adjusted for age, sex, socioeconomic status, duration of diabetes, body mass index, fasting blood glucose, systolic blood pressure, creatinine, smoking, alcohol consumption, exercise, pre-existing cardiovascular disease (ischemic heart disease, ischemic stroke, and heart failure), and concurrent medications (anti-thrombotic agents, anti-hypertensive agents by class, and anti-diabetic agents by class), and pre-treatment LDL-C level

Back to article page